• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19患者与非COVID-19患者急性肺损伤的对比研究

Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients.

作者信息

Zhang Jianguo, Huang Xing, Ding Daoyin, Zhang Jinhui, Xu Liusheng, Hu Zhenkui, Xu Wenrong, Tao Zhimin

机构信息

Jiangsu Province Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.

Department of Critical Care Medicine, The Affiliated Hospital, Jiangsu University, Zhenjiang, China.

出版信息

Front Med (Lausanne). 2021 Aug 16;8:666629. doi: 10.3389/fmed.2021.666629. eCollection 2021.

DOI:10.3389/fmed.2021.666629
PMID:34485324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8415545/
Abstract

Amid the coronavirus disease 2019 (COVID-19) pandemic, we analyzed clinical characteristics of acute lung injury (ALI) in COVID-19 patients and reported their similarity and dissimilarity to those of non-COVID-19 patients in the intensive care unit (ICU). We reported on 90 COVID-19 and 130 non-COVID-19 ALI patients in the ICUs of multiple centers. Demographic data, medical histories, laboratory findings, and radiological images were analyzed and compared between the two cohorts and within each cohort between survivors and non-survivors. For ALI survivors, clinical characteristics before and after treatment were also compared. Aberrations in blood parameters, such as leukocytosis, neutrophilia, and thrombocytopenia, were observed in both cohorts. More characteristic abnormalities, including significantly higher red cell distribution width (RDW), C-reactive proteins, and lactic dehydrogenase (LDH) but lower troponin (TnT) and procalcitonin, were observed in the COVID-19 cohort than in the non-COVID-19 cohort, whereas D-dimer levels showed a similar elevation in both cohorts. The COVID-19 cohort also showed more diversified CT patterns where severe features such as consolidations and crazy paving patterns were more frequently observed. Multivariate analysis indicated that age, fever symptom, prothrombin time, procalcitonin, partial pressure of carbon dioxide, oxygenated hemoglobin, and crazy paving patterns in CT scans were independent risk factors associated with COVID-19. Comparison of ALI characteristics between COVID-19 and non-COVID-19 patients in the ICU setting provided insight into the pathogenesis of ALI induced by different risk factors, suggesting distinct treatment plans.

摘要

在2019冠状病毒病(COVID-19)大流行期间,我们分析了COVID-19患者急性肺损伤(ALI)的临床特征,并报告了其与重症监护病房(ICU)中非COVID-19患者的异同。我们报告了多个中心ICU中的90例COVID-19和130例非COVID-19的ALI患者。对两组患者以及每组中幸存者和非幸存者之间的人口统计学数据、病史、实验室检查结果和影像学图像进行了分析和比较。对于ALI幸存者,还比较了治疗前后的临床特征。在两组中均观察到血液参数异常,如白细胞增多、中性粒细胞增多和血小板减少。与非COVID-19队列相比,COVID-19队列中观察到更多特征性异常,包括红细胞分布宽度(RDW)、C反应蛋白和乳酸脱氢酶(LDH)显著升高,但肌钙蛋白(TnT)和降钙素原较低,而两组中D-二聚体水平均有类似升高。COVID-19队列的CT表现也更多样化,其中实变和铺路石样改变等严重特征更常见。多变量分析表明,年龄、发热症状、凝血酶原时间、降钙素原、二氧化碳分压、氧合血红蛋白以及CT扫描中的铺路石样改变是与COVID-19相关的独立危险因素。在ICU环境中比较COVID-19和非COVID-19患者的ALI特征,有助于深入了解不同危险因素所致ALI的发病机制,从而提出不同的治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/8415545/8edef352174c/fmed-08-666629-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/8415545/8edef352174c/fmed-08-666629-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd0/8415545/8edef352174c/fmed-08-666629-g0001.jpg

相似文献

1
Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients.COVID-19患者与非COVID-19患者急性肺损伤的对比研究
Front Med (Lausanne). 2021 Aug 16;8:666629. doi: 10.3389/fmed.2021.666629. eCollection 2021.
2
Role of Biochemical Markers in Invasive Ventilation of Coronavirus Disease 2019 Patients: Multinomial Regression and Survival Analysis.生化标志物在2019冠状病毒病患者有创通气中的作用:多项回归与生存分析
Cureus. 2020 Aug 26;12(8):e10054. doi: 10.7759/cureus.10054.
3
Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study.从季节性流感中鉴别 COVID-19:一项多中心比较研究。
J Med Virol. 2021 Mar;93(3):1512-1519. doi: 10.1002/jmv.26469. Epub 2020 Sep 30.
4
Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.土耳其萨卡里亚市新冠肺炎危重症患者的特征和结局:一项单中心队列研究。
Turk J Med Sci. 2021 Apr 30;51(2):440-447. doi: 10.3906/sag-2005-57.
5
The correlation study on chest CT features and kidney injury in severe COVID-19 pneumonia from a multicenter cohort study.一项多中心队列研究:重症新型冠状病毒肺炎胸部CT特征与肾损伤的相关性研究
Chin J Acad Radiol. 2022;5(2):141-150. doi: 10.1007/s42058-022-00098-2. Epub 2022 Jun 2.
6
Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.预测新冠病毒疾病所致死亡的不良预后生化标志物:一项来自发展中国家的回顾性观察研究
Cureus. 2020 Aug 5;12(8):e9575. doi: 10.7759/cureus.9575.
7
Epidemiology, outcomes, and utilization of intensive care unit resources for critically ill COVID-19 patients in Libya: A prospective multi-center cohort study.利比亚危重新冠肺炎患者重症监护病房资源的流行病学、结局和利用:一项前瞻性多中心队列研究。
PLoS One. 2021 Apr 30;16(4):e0251085. doi: 10.1371/journal.pone.0251085. eCollection 2021.
8
Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.Covid-19:临床特征和实验室特征对早期发现高危重症患者的贡献。
Acta Clin Belg. 2022 Apr;77(2):261-267. doi: 10.1080/17843286.2020.1822078. Epub 2020 Sep 16.
9
Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism.计算机断层扫描特征及 COVID-19 肺炎合并静脉血栓栓塞症的结局评估。
PLoS One. 2020 Nov 19;15(11):e0242475. doi: 10.1371/journal.pone.0242475. eCollection 2020.
10
[Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].新型冠状病毒肺炎患者胸部CT评分的时空分布及预测价值
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):230-236. doi: 10.3760/cma.j.cn112147-20200522-00626.

引用本文的文献

1
Comparative analysis of demographic, clinical, biochemical, and predictors of mortality in COVID-19 and NON-COVID-19 ARDS patients: A retrospective cohort study.COVID-19和非COVID-19急性呼吸窘迫综合征患者的人口统计学、临床、生化特征及死亡率预测因素的比较分析:一项回顾性队列研究。
Medicine (Baltimore). 2025 Mar 21;104(12):e41851. doi: 10.1097/MD.0000000000041851.
2
Survival analysis of COVID-19 versus non-COVID-19 patients requiring intensive care for acute respiratory distress syndrome: An observational retrospective study.需要重症监护治疗急性呼吸窘迫综合征的新冠肺炎患者与非新冠肺炎患者的生存分析:一项观察性回顾性研究。
Can J Respir Ther. 2024 Aug 21;60:112-121. doi: 10.29390/001c.122402. eCollection 2024.
3

本文引用的文献

1
COVID-19 pneumonia and the appropriate use of antibiotics.新型冠状病毒肺炎与抗生素的合理使用。
Lancet Glob Health. 2020 Dec;8(12):e1453-e1454. doi: 10.1016/S2214-109X(20)30444-7. Epub 2020 Nov 11.
2
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis.COVID-19 患者接受有创机械通气的病死率:一项荟萃分析。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):54-66. doi: 10.1164/rccm.202006-2405OC.
3
Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection.
Effect of Hypertension Comorbidity on Clinical Characteristics of COVID-19 Patients Infected by the Wild-Type, the Delta or Omicron Variant SARS-CoV-2.
高血压合并症对感染野生型、德尔塔或奥密克戎变异株严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的2019冠状病毒病(COVID-19)患者临床特征的影响
Rev Cardiovasc Med. 2022 Dec 2;23(12):395. doi: 10.31083/j.rcm2312395. eCollection 2022 Dec.
4
Right heart echocardiography findings in hypoxic pneumonia patients during the COVID-19 pandemic in a South African population.南非人群中新冠疫情期间缺氧性肺炎患者的右心超声心动图检查结果
Eur Heart J Imaging Methods Pract. 2023 Oct 25;1(2):qyad030. doi: 10.1093/ehjimp/qyad030. eCollection 2023 Sep.
5
Red Blood Cell-Hitchhiking Delivery of Simvastatin to Relieve Acute Respiratory Distress Syndrome.红细胞搭便车递送辛伐他汀缓解急性呼吸窘迫综合征。
Int J Nanomedicine. 2024 Jun 6;19:5317-5333. doi: 10.2147/IJN.S460890. eCollection 2024.
6
The Top 100 Cited Articles Focusing on Acute Lung Injury and ARDS: Bibliometric and Visualization Analyses.100 篇聚焦急性肺损伤和急性呼吸窘迫综合征的高被引文章:计量学和可视化分析。
Respir Care. 2024 Jul 24;69(8):959-967. doi: 10.4187/respcare.11616.
7
Translational medicine for acute lung injury.急性肺损伤的转化医学。
J Transl Med. 2024 Jan 5;22(1):25. doi: 10.1186/s12967-023-04828-7.
8
Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review.急性呼吸窘迫综合征:治疗 COVID-19 进展的潜在治疗干预措施对治疗其他疾病进展的有效性-系统评价。
BMJ Open Respir Res. 2023 Sep;10(1). doi: 10.1136/bmjresp-2022-001525.
9
Investigating the link between miR-34a-5p and TLR6 signaling in sepsis-induced ARDS.研究脓毒症诱导的急性呼吸窘迫综合征中miR-34a-5p与TLR6信号传导之间的联系。
3 Biotech. 2023 Aug;13(8):282. doi: 10.1007/s13205-023-03700-1. Epub 2023 Jul 24.
10
Same but Different? Comparing the Epidemiology, Treatments and Outcomes of COVID-19 and Non-COVID-19 ARDS Cases in Germany Using a Sample of Claims Data from 2021 and 2019.相同但又不同?利用 2021 年和 2019 年索赔数据样本比较德国 COVID-19 和非 COVID-19 ARDS 病例的流行病学、治疗方法和结局。
Viruses. 2023 Jun 5;15(6):1324. doi: 10.3390/v15061324.
红细胞分布宽度与住院成人 SARS-CoV-2 感染患者死亡风险的关联。
JAMA Netw Open. 2020 Sep 1;3(9):e2022058. doi: 10.1001/jamanetworkopen.2020.22058.
4
Differentiation of COVID-19 from seasonal influenza: A multicenter comparative study.从季节性流感中鉴别 COVID-19:一项多中心比较研究。
J Med Virol. 2021 Mar;93(3):1512-1519. doi: 10.1002/jmv.26469. Epub 2020 Sep 30.
5
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.血管紧张素转化酶 2(ACE2)在 COVID-19 中的作用。
Crit Care. 2020 Jul 13;24(1):422. doi: 10.1186/s13054-020-03120-0.
6
ACE2, Much More Than Just a Receptor for SARS-COV-2.ACE2,远不止是 SARS-CoV-2 的受体。
Front Cell Infect Microbiol. 2020 Jun 5;10:317. doi: 10.3389/fcimb.2020.00317. eCollection 2020.
7
Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan.新型冠状病毒肺炎患者管理中的有创机械通气:武汉469例患者的经验
Crit Care. 2020 Jun 16;24(1):348. doi: 10.1186/s13054-020-03044-9.
8
Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.早期使用抗生素对新冠肺炎危重症患者的死亡率没有影响。
J Infect. 2020 Aug;81(2):e148-e149. doi: 10.1016/j.jinf.2020.06.004. Epub 2020 Jun 5.
9
Acute lung injury in patients with COVID-19 infection.新型冠状病毒肺炎(COVID-19)感染患者的急性肺损伤
Clin Transl Med. 2020 Jan;10(1):20-27. doi: 10.1002/ctm2.16. Epub 2020 Mar 31.
10
Regulation of alveolar type 2 stem/progenitor cells in lung injury and regeneration.肺泡 II 型干细胞/祖细胞在肺损伤与再生中的调控作用。
Acta Biochim Biophys Sin (Shanghai). 2020 Jul 10;52(7):716-722. doi: 10.1093/abbs/gmaa052.